Trial Profile
Rituxan injection drug use-results survey in ABO-incompatible liver transplantation recipients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2020
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical; Zenyaku Kogyo
- 30 May 2016 New trial record